206 related articles for article (PubMed ID: 12061205)
1. [Hepatic encephalopathy after TIPS--retrospective study].
Stefánková J; Fejfar T; Safka V; Hůlek P; Krajina A; Fendrichová M
Vnitr Lek; 2002 May; 48(5):390-5. PubMed ID: 12061205
[TBL] [Abstract][Full Text] [Related]
2. Hepatic encephalopathy due to TIPS--retrospective study.
Stefánková J; Hůleki P; Babu A; Cermáková E; Safka V; Stefanek J; Fejfar T; Krajina A
Hepatogastroenterology; 2007 Mar; 54(74):480-4. PubMed ID: 17523303
[TBL] [Abstract][Full Text] [Related]
3. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
4. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
6. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
Masson S; Mardini HA; Rose JD; Record CO
QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
[TBL] [Abstract][Full Text] [Related]
7. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
8. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
[TBL] [Abstract][Full Text] [Related]
10. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
Deng D; Liao MS; Qin JP; Li XA
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
[TBL] [Abstract][Full Text] [Related]
14. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma.
Bañares R; Núñez O; Escudero M; Fernández C; Vaquero J; Beceiro I; Echenagusía A; Clemente G; Santos L
Hepatology; 2005 Mar; 41(3):566-71. PubMed ID: 15726654
[TBL] [Abstract][Full Text] [Related]
15. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.
Somberg KA; Riegler JL; LaBerge JM; Doherty-Simor MM; Bachetti P; Roberts JP; Lake JR
Am J Gastroenterol; 1995 Apr; 90(4):549-55. PubMed ID: 7717309
[TBL] [Abstract][Full Text] [Related]
16. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
Wallace MJ; Madoff DC; Ahrar K; Warneke CL
Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
20. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]